MedTrace Logo

Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation

NCT00577902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2016-02-09

No results posted yet for this study

Summary

This study is being conducted to define the specific nutritional biomarkers and nutritional risk during the course of chemoradiation therapy for cancers of the head and neck. This prospective, longitudinal observational study is focused on specific antioxidants and B vitamins. The ORAC was selected as an index of overall antioxidant capacity. We chose to evaluate antioxidant status because administering antioxidants has been shown to reduce chemotherapeutic agent toxicities.

Conditions

Interventions

OTHER

Observation

Head and neck cancer patients receiving chemoradiation

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Jean Hine, PhD · University of Arkansas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00577902 on ClinicalTrials.gov